Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozole.
Fasching PA, Hack CC, Nabieva N, Maass N, Aktas B, Kümmel S, Thomssen C, Wolf C, Kolberg HC, Brucker C, Janni W, Dall P, Schneeweiss A, Marme F, Sütterlin MW, Ruebner M, Theuser AK, Kellner S, Hofmann NM, Böhm S, Almstedt K, Lück HJ, Schmatloch S, Kalder M, Uleer C, Jurhasz-Böss I, Hanf V, Jackisch C, Müller V, Rack B, Belleville E, Wallwiener D, Rody A, Rauh C, Bayer CM, Uhrig S, Goossens C, Huebner H, Brucker SY, Hein A, Fehm TN, Häberle L. Fasching PA, et al. Among authors: theuser ak. Eur J Cancer. 2024 Sep;209:114239. doi: 10.1016/j.ejca.2024.114239. Epub 2024 Jul 21. Eur J Cancer. 2024. PMID: 39059184 Free article.
Correction: Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care - The PreFace Study.
Hack CC, Maass N, Aktas B, Kümmel S, Thomssen C, Wolf C, Kolberg HC, Brucker C, Janni W, Dall P, Schneeweiss A, Marme F, Ruebner M, Theuser AK, Hofmann NM, Böhm S, Almstedt K, Kellner S, Nabieva N, Gass P, Sütterlin MW, Lück HJ, Schmatloch S, Kalder M, Uleer C, Juhasz-Böss I, Hanf V, Jackisch C, Müller V, Rack B, Belleville E, Wallwiener D, Rody A, Rauh C, Bayer CM, Uhrig S, Goossens C, Huebner H, Brucker SY, Häberle L, Fehm TN, Hein A, Fasching PA. Hack CC, et al. Among authors: theuser ak. Geburtshilfe Frauenheilkd. 2024 Apr 30;84(2):e10. doi: 10.1055/a-2314-3693. eCollection 2024 Feb. Geburtshilfe Frauenheilkd. 2024. PMID: 38690326 Free PMC article.
Primary results of the AGO-Zervix-1 Study: A prospective, randomized phase III study to compare the effects of paclitaxel and topotecan with those of cisplatin and topotecan in the treatment of patients with recurrent and persistent cervical cancer.
Gass P, Thiel FC, Häberle L, Ackermann S, Theuser AK, Hummel N, Boehm S, Kimmig R, Reinthaller A, Becker S, Hilpert F, Janni W, Vergote I, Harter P, Emons J, Hein A, Beckmann MW, Fasching PA, Pöschke P; AGO Uterus Commission. Gass P, et al. Among authors: theuser ak. Gynecol Oncol. 2024 Apr;183:25-32. doi: 10.1016/j.ygyno.2024.03.002. Epub 2024 Mar 14. Gynecol Oncol. 2024. PMID: 38490057 Free article. Clinical Trial.
Impact of the Corona Pandemic on Cervical Cancer Screening Assessment.
Stuebs FA, Behrens AS, Seibold A, Adler W, Geppert C, Hartmann A, Knöll A, Koch MC, Mehlhorn G, Beckmann MW, Theuser AK, Schulmeyer CE, Gass P, Dietl AK. Stuebs FA, et al. Among authors: theuser ak. In Vivo. 2024 Mar-Apr;38(2):734-740. doi: 10.21873/invivo.13495. In Vivo. 2024. PMID: 38418110 Free PMC article.
Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care - The PreFace Study.
Hack CC, Maass N, Aktas B, Kümmel S, Thomssen C, Wolf C, Kolberg HC, Brucker C, Janni W, Dall P, Schneeweiss A, Marme F, Ruebner M, Theuser AK, Hofmann NM, Böhm S, Almstedt K, Kellner S, Gass P, Sütterlin MW, Lück HJ, Schmatloch S, Kalder M, Uleer C, Juhasz-Böss I, Hanf V, Jackisch C, Müller V, Rack B, Belleville E, Wallwiener D, Rody A, Rauh C, Bayer CM, Uhrig S, Goossens C, Huebner H, Brucker SY, Häberle L, Fehm TN, Hein A, Fasching PA. Hack CC, et al. Among authors: theuser ak. Geburtshilfe Frauenheilkd. 2024 Feb 8;84(2):185-195. doi: 10.1055/a-2238-3153. eCollection 2024 Feb. Geburtshilfe Frauenheilkd. 2024. PMID: 38344045 Free PMC article.
Pembrolizumab in combination with nab-paclitaxel for the treatment of patients with early-stage triple-negative breast cancer - A single-arm phase II trial (NeoImmunoboost, AGO-B-041).
Fasching PA, Hein A, Kolberg HC, Häberle L, Uhrig S, Rübner M, Belleville E, Hack CC, Fehm TN, Janni W, Hartmann A, Erber R, Theuser AK, Brucker SY, Hartkopf AD, Untch M. Fasching PA, et al. Among authors: theuser ak. Eur J Cancer. 2023 May;184:1-9. doi: 10.1016/j.ejca.2023.01.001. Epub 2023 Jan 9. Eur J Cancer. 2023. PMID: 36871424 Free article. Clinical Trial.
Gynecologists' attitudes toward and use of complementary and integrative medicine approaches: results of a national survey in Germany.
Grimm D, Voiss P, Paepke D, Dietmaier J, Cramer H, Kümmel S, Beckmann MW, Woelber L, Schmalfeldt B, Freitag U, Kalder M, Wallwiener M, Theuser AK, Hack CC. Grimm D, et al. Among authors: theuser ak. Arch Gynecol Obstet. 2021 Apr;303(4):967-980. doi: 10.1007/s00404-020-05869-9. Epub 2020 Nov 17. Arch Gynecol Obstet. 2021. PMID: 33201377 Free PMC article.
Supportive Infusions in Integrative Breast and Gynecological Oncology - Report on Patients' Satisfaction and Self-reported Effects and Side Effects.
Hack CC, Antoniadis S, Beckmann MW, Brandl AL, Fasching PA, Hackl J, Langemann H, Katja S, Weber N, Theuser AK. Hack CC, et al. Among authors: theuser ak. Geburtshilfe Frauenheilkd. 2018 Nov;78(11):1129-1137. doi: 10.1055/a-0754-2923. Epub 2018 Nov 26. Geburtshilfe Frauenheilkd. 2018. PMID: 30498280 Free PMC article.
13 results